Dr. Stanley Schwartz is an Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa.. Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago.
Dr. Schwartz actively lectures nationally, as well as internationally, about diabetes and its treatment. In the past 2 years he has been a speaker in Istanbul, Switzerland, Belgium, Tunisia , 4 cities in China, at the 30th International Symposium on Intensive Care and Emergency Medicine,and atAACE 2011. He has authored numerous articles in peer-reviewed scientific journals and has been a lead or co-investigator for many clinical trials (DCCT-EDIC, LOOK AHEAD).
Since leaving Penn, he received an R-01 from the NIH for studying the Genes related to LADA, wrote 2 book chapters which are in press (CGMS, Weight reduction in DM), and has one journal article in press (incretins in hospital). He is a major author of the Self-assessment Program of the American Diabetes Assoc (2007 and 2008) , the 2009/2010 AACE Guidelines and Primary Care , and CME slide modules for primary care for AACE, 2011.. He is a member or fellow of international, national, and local professional societies including an Overseas Fellow of the Royal Society of Medicine (London), European Association for the Study of Diabetes (EASD), the International Diabetes Federation (IDF), the American Diabetes Association (ADA), the American Endocrine Society (ES), College of Physicians in Philadelphia, and the American College of Physicians (ACP). Though he does some research and teaches a great deal, most of his time is spent caring for patients .